Ligufalimab (anti-CD47)
|
Ab191922-1mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
2428381-55-7 |
1mg
|
¥ 3039.9
|
现货 |
阿拉丁 |
Ligufalimab (anti-CD47)
|
Ab191922-10mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
2428381-55-7 |
10mg
|
¥ 12159.9
|
期货,请咨询 |
阿拉丁 |
Ligufalimab (anti-CD47)
|
Ab191922-100μg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
2428381-55-7 |
100μg
|
¥ 609.9
|
现货 |
阿拉丁 |
NIS-793 (anti-TGFb1)
|
Ab191917-5mg
|
无载体, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2649854-92-0 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
NIS-793 (anti-TGFb1)
|
Ab191917-1mg
|
无载体, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2649854-92-0 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
NIS-793 (anti-TGFb1)
|
Ab191917-10mg
|
无载体, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2649854-92-0 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
NIS-793 (anti-TGFb1)
|
Ab191917-100μg
|
无载体, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2649854-92-0 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Nofazinlimab (anti-PDCD1)
|
Ab191907-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2377845-98-0 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Nofazinlimab (anti-PDCD1)
|
Ab191907-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2377845-98-0 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Nofazinlimab (anti-PDCD1)
|
Ab191907-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2377845-98-0 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Nofazinlimab (anti-PDCD1)
|
Ab191907-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2377845-98-0 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Opucolimab (anti-PD-L1)
|
Ab191899-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2251771-79-4 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Opucolimab (anti-PD-L1)
|
Ab191899-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2251771-79-4 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Opucolimab (anti-PD-L1)
|
Ab191899-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2251771-79-4 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Opucolimab (anti-PD-L1)
|
Ab191899-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2251771-79-4 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Sudubrilimab (anti-PD-L1)
|
Ab191897-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2387417-06-1 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Sudubrilimab (anti-PD-L1)
|
Ab191897-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2387417-06-1 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Sudubrilimab (anti-PD-L1)
|
Ab191897-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2387417-06-1 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Sudubrilimab (anti-PD-L1)
|
Ab191897-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2387417-06-1 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Ifabotuzumab (anti-EphA3)
|
Ab191893-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2147698-66-4 |
5mg
|
¥ 6329.9
|
期货,请咨询 |
阿拉丁 |
Ifabotuzumab (anti-EphA3)
|
Ab191893-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2147698-66-4 |
1mg
|
¥ 2859.9
|
期货,请咨询 |
阿拉丁 |
Ifabotuzumab (anti-EphA3)
|
Ab191893-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2147698-66-4 |
10mg
|
¥ 10299.9
|
期货,请咨询 |
阿拉丁 |
Ifabotuzumab (anti-EphA3)
|
Ab191893-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2147698-66-4 |
100μg
|
¥ 569.9
|
期货,请咨询 |
阿拉丁 |
Favezelimab (anti-LAG3)
|
Ab190152-10mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
2231068-83-8 |
10mg
|
¥ 12159.9
|
期货,请咨询 |
阿拉丁 |